Buscar
01/06/2025
Pituitary Apoplexy: Comorbidities, Management, and Outcomes-A Spanish Observational Multicenter Study
Biagetti, B, Asanza, EC, Pérez-López, C, Araujo-Castro, M, Camara, R, Guerrero-Pérez, F, Vicente, A, Lamas, C, Serra, G, Echarri, AI, Ollero, MD, Molero, IG, Villar-Taibo, R, Rodríguez, MDM, Garcia-Feijoo, P, Berrocal, VR, Ramirez, MNS, Hurtado, AG, Capristan-Díaz, V, Simó-Servat, A, Gallach, M, Perez, ES, Rosa, VG, Civantos, S, Asensio-Wandosell, D, Martinez-Saez, E, Torre, EM, Aulinas, A, Iglesias, P, Diez, JJ, Bernábeu, I, Alvarez-Escolá, C, Puig-Domingo, M. Pituitary Apoplexy: Comorbidities, Management, and Outcomes-A Spanish Observational Multicenter Study. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(6)DOI:10.1210/clinem/dgae649. PMID:39298667. IF:5.100(Q1/2D).
01/02/2025
Increased copeptin may reflect vasopressin-related metabolic changes after bariatric surgery
Galbiati, F, Becetti, I, Lauze, M, Aulinas, A, Singhal, V, Bredella, MA, Lawson, EA, Misra, M. Increased copeptin may reflect vasopressin-related metabolic changes after bariatric surgery. Obesity. 2025; 33(2)DOI:10.1002/oby.24200. PMID:39725569. IF:4.700(Q1/2D).
01/02/2025
Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study
Guerrero-Pérez, F, Biagetti, B, Paja-Fano, M, Menéndez-Torre, EL, Rivero, G, Dios, E, Hanzu, FA, Rojas-Marcos, PM, Irigaray, A, Rodríguez, MDM, García-Centeno, R, Fernández, LG, Enseñat, J, Mora, M, Villar-Taibo, R, García, IMO, Araujo-Castro, M, Gándara, C, García, MDO, Tenorio-Jiménez, C, Novo-Rodriguez, C, Civantos, S, Simó-Servat, A, Aulinas, A, Asla, Q, Cordido, F, Novoa-Testa, I, Xifra, G, Ayala-Conte, M, Zamarron, A, Berrocal, MIG, Iglesias, P. Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study. Pituitary. 2025; 28(1)DOI:10.1007/s11102-024-01484-y. PMID:39733084. IF:3.400(Q2/4D).
01/09/2024
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs (vol 31, e240043, 2024)
Araujo-Castro, M, Biagetti, B, Torre, EM, Novoa-Testa, I, Cordido, F, Pascual-Corrales, E, Berrocal, VR, Guerrero-Perez, F, Vicente, A, Hualpa, JCP, Garcia-Centeno, R, Gonzalez-Fernandez, L, Garcia, MDO, Echarri, AI, Rodriguez, MDM, Novo-Rodriguez, C, Calatayud, M, Villar-Taibo, R, Bernabeu, I, Alvarez-Escola, C, Valderrama, PB, Tenorio-Jimenez, C, Galiana, PA, Venegas, E, Gonzalez-Molero, I, Iglesias, P, Blanco-Carrera, C, De Lara, FVO, Novoa, PD, Mezquita, EL, Hanzu, FA, Aldecoa, I, Aznar, S, Lamas, C, Aulinas, A, Asla, Q, Gimeno, PG, Recio-Cordova, JM, Aviles-Perez, MD, Asensio-Wandosell, D, Sampedro-Nunez, M, Camara, R, Fano, MP, Ruz-Caracuel, I, Fajardo, C, Marazuela, M, Puig-Domingo, M. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs (vol 31, e240043, 2024). ENDOCRINE-RELATED CANCER. 2024; 31(9)DOI:10.1530/ERC-24-0043e. PMID:. IF:4.600(Q1/3D).
13/08/2024
Personalized Medicine in Acromegaly: The ACROFAST Study
Marques-Pamies, M, Gil, J, Sampedro-Nuñez, M, Valassi, E, Biagetti, B, Giménez-Palop, O, Hernández, M, Martínez, S, Carrato, C, Villar-Taibo, R, Araujo-Castro, M, Blanco, C, Simón-Muela, I, Simó-Servat, A, Xifra, G, Vázquez, F, Pavón, I, Rosado, JA, García-Centeno, R, Zavala, R, Hanzu, FA, Mora, M, Aulinas, A, Vilarrasa, N, Librizzi, S, Calatayud, M, de Miguel, P, Alvarez-Escola, C, Picó, A, Salinas, I, Fajardo-Montañana, C, Cámara, R, Bernabéu, I, Jordà, M, Webb, SM, Marazuela, M, Puig-Domingo, M. Personalized Medicine in Acromegaly: The ACROFAST Study. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2024; 110(1)DOI:10.1210/clinem/dgae444. PMID:38943661. IF:5.100(Q1/2D).
01/08/2024
Association between inadequate weight gain according to the institute of medicine 2009 guidelines and pregnancy outcomes in women with thyroid disorders
Liu, JM, Xie, XL, García-Patterson, A, Asla, Q, Sardà, H, Chico, A, Adelantado, JM, Urgell, E, Corcoy, R. Association between inadequate weight gain according to the institute of medicine 2009 guidelines and pregnancy outcomes in women with thyroid disorders. ARCHIVES OF GYNECOLOGY AND OBSTETRICS. 2024; 310(2)DOI:10.1007/s00404-023-07279-z. PMID:37981602. IF:2.500(Q2/3D).
17/07/2024
Circulating miR-28-5p is overexpressed in patients with sarcopenia despite long-term remission of Cushing's syndrome: a pilot study
Seco-Cervera, M, Ibáñez-Cabellos, JS, Pallardo, FV, García-Giménez, JL, Aulinas, A, Martel-Duguech, L, Webb, SM, Valassi, E. Circulating miR-28-5p is overexpressed in patients with sarcopenia despite long-term remission of Cushing's syndrome: a pilot study. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1410080. PMID:39086897. IF:4.600(Q1/3D).
01/07/2024
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Araujo-Castro, M, Biagetti, B, Torre, EM, Novoa-Testa, I, Cordido, F, Pascual-Corrales, E, Berrocal, VR, Guerrero-Pérez, F, Vicente, A, Hualpa, JCP, García-Centeno, R, González-Fernández, L, García, MDO, Echarri, AI, Rodríguez, MDM, Novo-Rodríguez, C, Calatayud, M, Villar-Taibo, R, Bernabéu, I, Alvarez-Escola, C, Valderrama, PB, Tenorio-Jiménez, C, Galiana, PA, Venegas, E, González-Molero, I, Iglesias, P, Blanco-Carrera, C, De Lara, FVO, Novoa, PD, Mezquita, EL, Hanzu, FA, Aldecoa, I, Aznar, S, Lamas, C, Aulinas, A, Asla, Q, Gimeno, PG, Recio-Córdova, JM, Avilés-Pérez, MD, Asensio-Wandosell, D, Sampedro-Núñez, M, Cámara, R, Fano, MP, Ruz-Caracuel, I, Fajardo, C, Marazuela, M, Puig-Domingo, M. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs. ENDOCRINE-RELATED CANCER. 2024; 31(7)DOI:10.1530/ERC-24-0043. PMID:38713182. IF:4.600(Q1/3D).
28/06/2024
Medical Comorbidities, Nutritional Markers, and Cardiovascular Risk Markers in Youth With ARFID
Burton-Murray, H, Sella, AC, Gydus, JE, Atkins, M, Palmer, LP, Kuhnle, MC, Becker, KR, Breithaupt, LE, Brigham, KS, Aulinas, A, Staller, K, Eddy, KT, Misra, M, Micali, N, Thomas, JJ, Lawson, EA. Medical Comorbidities, Nutritional Markers, and Cardiovascular Risk Markers in Youth With ARFID. INTERNATIONAL JOURNAL OF EATING DISORDERS. 2024; 57(11)DOI:10.1002/eat.24243. PMID:38940228. IF:4.300(Q1/1D).
28/06/2024
Glucose metabolism outcomes after pituitary surgery in patients with acromegaly
Pascual-Corrales, E, Biagetti, B, Marazuela, M, Asensio-Wandosel, D, Berrocal, VR, Echarri, AI, Novo-Rodriguez, C, Calatayud, M, Bernabeu, I, Alvarez-Escola, C, Tenorio-Jimenez, C, Molero, IG, Iglesias, P, Blanco, C, de Miguel, P, Mezquita, EL, Lamas, C, Aulinas, A, Gracia, P, Recio-Cordova, JM, Sampedro-Nunez, M, Paja, M, Rodríguez, MDM, Fajardo-Montañana, C, Cordido, F, Torre, EM, Percovich, JC, García-Centeno, R, Cámara, R, Hanzu, FA, Delgado, AV, Fernández, LG, Guerrero-Pérez, F, Garcia-Agullo, MDO, Novoa-Testa, I, Villar-Taibo, R, Valderrama, PB, Galiana, PA, Moreno, EV, De Lara, FVO, Enseñat, J, Aznar, S, Asla, Q, Aviles-Pérez, MD, Puig-Domingo, M, Araujo-Castro, M. Glucose metabolism outcomes after pituitary surgery in patients with acromegaly. Pituitary. 2024; 27(5)DOI:10.1007/s11102-024-01415-x. PMID:38940859. IF:3.400(Q2/4D).
17/06/2024
Natural history and surgical outcomes of Rathke's cleft cysts: a Spanish multicenter study
Menéndez-Torre, EL, Gutiérrez-Hurtado, A, Ollero, MD, Irigaray, A, Martín, P, Parra, P, González-Molero, I, Araujo-Castro, M, Idrobo, C, Moure, MD, Molina, AR, Biagetti, B, Iglesias, P, Paja, M, Villar-Taibo, R, Pena, A, Vicente, A, Guerrero-Pérez, F, Cordido, F, Aulinas, A, Mateu, M, Soto, A. Natural history and surgical outcomes of Rathke's cleft cysts: a Spanish multicenter study. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1413810. PMID:38952395. IF:4.600(Q1/3D).
12/06/2024
Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion
Biagetti, B, Araujo-Castro, M, Torre, EM, Novoa-Testa, I, Cordido, F, Corrales, EP, Berrocal, VR, Guerrero-Perez, F, Vicente, A, Percovich, JC, Centeno, RG, Gonzalez, L, Garcia, MDO, Echarri, AI, Rodriguez, MDM, Novo-Rodriguez, C, Calatayud, M, Villar-Taibo, R, Bernabeu, I, Alvarez-Escola, C, Valderrama, PB, Tenorio-Jimenez, C, Galiana, PA, Moreno, EV, Molero, IG, Iglesias, P, Blanco, C, De Lara, FVO, de Miguel, P, Mezquita, EL, Hanzu, F, Aldecoa, I, Aznar, S, Lamas, C, Aulinas, A, Roca, QA, Gracia, P, Cordova, JMR, Aviles, M, Asensio-Wandosel, D, Sampedro, M, Camara, R, Paja, M, Ruz-Caracuel, I, Fajardo-Montanana, C, Asanza, EC, Martinez-Saez, E, Marazuela, M, Puig-Domingo, M. Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2024; 190(6)DOI:10.1093/ejendo/lvae053. PMID:38771697. IF:5.200(Q1/2D).
01/06/2024
Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey
Cherenko, M, Appelman-Dijkstra, NM, Zurita, ALP, Biermasz, NR, Dekkers, OM, Klok, FA, Reisch, N, Aulinas, A, Biagetti, B, Cannavo, S, Canu, L, Detomas, M, Devuyst, F, Falhammar, H, Feelders, RA, Ferrau, F, Gatto, F, Grasselli, C, van Houten, P, Hoybye, C, Isidori, AM, Kyrilli, A, Loli, P, Maiter, D, Nowak, E, Pivonello, R, Ragnarsson, O, Steenaard, R, Unger, N, van de Ven, A, Webb, SM, Yeste, D, Ahmed, SF, Pereira, AM. Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey. Endocrine Connections. 2024; 13(6)DOI:10.1530/EC-24-0046. PMID:38614126. IF:2.800(Q3/6D).
13/03/2024
PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly (vol 40, pg 671, 2023)
O'Toole, D, Kunz, PL, Webb, SM, Goldstein, G, Khawaja, S, McDonnell, M, Boiziau, S, Gueguen, D, Houchard, A, Ribeiro-Oliveira, A Jr, Prebtani, A. PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly (vol 40, pg 671, 2023). ADVANCES IN THERAPY. 2024; 41(6)DOI:10.1007/s12325-024-02829-6. PMID:38480663. IF:4.000(Q1/3D).
11/03/2024
The thrombotic risk in Cushing's syndrome-questions, answers, and the algorithm to consider in its assessment: part I-thrombotic risk not related to surgery
Bryk-Wiazania, AH, Minasyan, M, Swiatkowska-Stodulska, R, Undas, A, Hubalewska-Dydejczyk, A, Webb, SM, Valassi, E, Gilis-Januszewska, A. The thrombotic risk in Cushing's syndrome-questions, answers, and the algorithm to consider in its assessment: part I-thrombotic risk not related to surgery. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1350010. PMID:38529392. IF:4.600(Q1/3D).
04/03/2024
Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases
Araujo-Castro, M, Biagetti, B, Torre, EM, Novoa-Testa, I, Cordido, F, Corrales, EP, Berrocal, VR, Guerrero-Pérez, F, Vicente, A, Percovich, JC, Centeno, RG, González, L, García, MDO, Echarri, AI, Rodríguez, MDM, Novo-Rodríguez, C, Calatayud, M, Villar, R, Bernabéu, I, Alvarez-Escola, C, Valderrama, PB, Tenorio-Jimenéz, C, Galiana, PA, Moreno, EV, Molero, IG, Iglesias, P, Blanco, C, De Lara, FVO, de Miguel, P, Mezquita, EL, Hanzu, F, Aldecoa, I, Lamas, C, Aznar, S, Aulinas, A, Calabrese, A, Gracia, P, Recio-Córdova, JM, Aviles, M, Asensio-Wandosel, D, Sampedro, M, Ruz-Caracuel, I, Camara, R, Paja, M, Fajardo-Montañana, C, Marazuela, M, Puig-Domingo, M. Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2024; 109(12)DOI:10.1210/clinem/dgae126. PMID:38436926. IF:5.100(Q1/2D).
01/01/2024
New molecular tools for precision medicine in pituitary neuroendocrine tumors
Marques-Pamies, M, Gil, J, Valassi, E, Pons, L, Carrato, C, Jordà, M, Puig-Domingo, M. New molecular tools for precision medicine in pituitary neuroendocrine tumors. Minerva Endocrinology. 2024; 49(3)DOI:10.23736/S2724-6507.23.04063-0. PMID:38261299. IF:1.900(Q3/8D).
01/12/2023
Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly
Marques-Pamies, M, Gil, J, Jordà, M, Puig-Domingo, M. Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly. ARCHIVES OF MEDICAL RESEARCH. 2023; 54(8)DOI:10.1016/j.arcmed.2023.102924. PMID:38042683. IF:4.700(Q1/3D).
31/10/2023
Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly
Marques-Pamies, M, Gil, J, Valassi, E, Hernández, M, Biagetti, B, Giménez-Palop, O, Martínez, S, Carrato, C, Pons, L, Villar-Taibo, R, Araujo-Castro, M, Blanco, C, Simón, I, Simó-Servat, A, Xifra, G, Vázquez, F, Pavón, I, García-Centeno, R, Zavala, R, Hanzu, FA, Mora, M, Aulinas, A, Vilarrasa, N, Librizzi, S, Calatayud, M, de Miguel, P, Alvarez-Escola, C, Picó, A, Sampedro, M, Salinas, I, Fajardo-Montañana, C, Cámara, R, Bernabéu, I, Jordà, M, Webb, SM, Marazuela, M, Puig-Domingo, M. Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1269787. PMID:38027102. IF:3.900(Q2/3D).
02/08/2023
Oxytocin response to food intake in avoidant/restrictive food intake disorder
Aulinas, A, Muhammed, M, Becker, KR, Asanza, E, Hauser, K, Stern, C, Gydus, J, Holmes, T, Murray, HB, Breithaupt, L, Micali, N, Misra, M, Eddy, KT, Thomas, JJ, Lawson, EA. Oxytocin response to food intake in avoidant/restrictive food intake disorder. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2023; 189(2)DOI:10.1093/ejendo/lvad087. PMID:37474111. IF:5.300(Q1/2D).